13F-HR filed by Altium Capital Management LLC
Altium Capital Management LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 72 holding rows worth $252,672,017.
- Accession
- 0001420506-24-000943
- Filer
- CIK 1746382
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 72 entries on the cover page, a total value of $252,672,017 stated on the cover page (in dollars after the unit check, H1), rows summing to $252,672,017 with VALUE read as dollars as filed, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 710,000 | $30,615,200 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 348,000 | $14,981,400 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J956 | COM | 175,300 | $14,374,600 | dollars as filed | put |
| ADVISORSHARES TR | 00768Y903 | CALL | 1,125,000 | $11,261,250 | dollars as filed | call |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 138,000 | $11,012,400 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,540,000 | $10,164,000 | dollars as filed | |
| ALIMERA SCIENCES INC | 016259202 | COM | 2,550,000 | $9,945,000 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 553,057 | $9,341,133 | dollars as filed | |
| XTANT MED HLDGS INC | 98420P308 | COM NEW | 7,647,873 | $8,948,011 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 500,000 | $7,970,000 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 113,000 | $7,819,600 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 140,000 | $7,656,600 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 85,000 | $6,970,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 605,000 | $6,848,600 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,335,000 | $6,648,300 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 152,909 | $6,544,505 | dollars as filed | |
| CYBIN INC | 23256X100 | COM | 13,953,488 | $5,769,767 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 405,000 | $5,568,750 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 695,000 | $5,275,050 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 208,000 | $5,224,960 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 100,000 | $5,090,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 78,100 | $4,765,662 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 835,470 | $3,797,211 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 25,000 | $3,779,250 | dollars as filed | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 170,000 | $3,672,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 120,000 | $3,255,600 | dollars as filed | |
| THE REALREAL INC | 88339P101 | COM | 800,000 | $3,128,000 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 77,848 | $3,085,895 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 200,000 | $2,850,000 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 665,000 | $2,832,900 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 57,271 | $2,481,552 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 1,212,882 | $2,171,059 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 142,532 | $2,006,138 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 341,461 | $1,980,474 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E909 | CALL | 200,000 | $1,796,000 | dollars as filed | call |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 176,840 | $1,598,634 | dollars as filed | |
| BIOVIE INC | 09074F207 | COM | 3,012,608 | $1,592,465 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 65,442 | $1,498,622 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 2,111,731 | $1,478,423 | dollars as filed | |
| GERON CORP | 374163903 | COM | 400,000 | $1,320,000 | dollars as filed | call |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 740,000 | $1,117,400 | dollars as filed | |
| FAT BRANDS INC | 30258N121 | *W EXP 07/16/202 | 200,000 | $974,000 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 1,150,000 | $903,785 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V104 | COM | 535,657 | $637,432 | dollars as filed | |
| EVOKE PHARMA INC | 30049G203 | COM NEW | 724,942 | $442,215 | dollars as filed | |
| PERFECT MOMENT LTD | 713715100 | COM SHS | 92,208 | $330,105 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 731,561 | $218,883 | dollars as filed | |
| NEXGEL INC | 65344E115 | *W EXP 12/27/202 | 225,000 | $162,000 | dollars as filed | |
| MOBILICOM ORD | 60742B102 | COM | 135,292 | $160,997 | dollars as filed | |
| GRI BIO INC | 3622AW205 | COM NEW | 187,981 | $142,866 | dollars as filed | |
| WEARABLE DEVICES LTD | M97838110 | *W EXP 09/14/202 | 1,411,600 | $109,470 | dollars as filed | |
| AZITRA INC | 05479L104 | COM | 493,153 | $101,343 | dollars as filed | |
| NOCTURNE ACQUISITION CORP | G6580S106 | RIGHT 12/26/2025 | 500,000 | $82,000 | dollars as filed | |
| QUOIN PHARMACEUTICALS ADR | 74907L300 | COM | 66,240 | $62,928 | dollars as filed | |
| MOBIX LABS INC | 60743G118 | *W EXP 12/21/202 | 150,000 | $31,500 | dollars as filed | |
| DIGITAL HEALTH ACQUISITION C | 253893119 | *W EXP 99/99/999 | 150,000 | $19,245 | dollars as filed | |
| ONFOLIO HOLDINGS INC | 68277K124 | *W EXP 01/02/202 | 200,000 | $8,120 | dollars as filed | |
| NLS PHARMACEUTICS LTD | H57830111 | *W EXP 02/02/202 | 200,000 | $6,880 | dollars as filed | |
| Cdt Equity Inc W Exp 09/22/202 | 20678X114 | SPAC Combination | 100,000 | $6,000 | dollars as filed | |
| Cingulate Inc W Exp 12/10/202 | 17248W113 | Warrant | 270,000 | $5,697 | dollars as filed | |
| BITCOIN DEPOT INC | 09174P113 | *W EXP 06/30/202 | 50,000 | $4,745 | dollars as filed | |
| NEXALIN TECHNOLOGY INC | 65345B110 | *W EXP 99/99/999 | 105,000 | $4,389 | dollars as filed | |
| CYCURION INC | 95758L115 | *W EXP 02/13/203 | 100,000 | $4,275 | dollars as filed | |
| NEXERA TECHNOLOGIES LTD | M61472110 | *W EXP 08/26/202 | 68,681 | $4,011 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 82,233 | $3,404 | dollars as filed | |
| CEA INDUSTRIES INC | 86887P119 | *W EXP 02/11/202 | 250,000 | $3,250 | dollars as filed | |
| PROSOMNUS INC | 50535E116 | *W EXP 04/20/202 | 150,000 | $3,000 | dollars as filed | |
| COLISEUM ACQUISITION CORP | G2263T107 | *W EXP 08/22/202 | 28,333 | $1,870 | dollars as filed | |
| BOA ACQUISITION CORP | g8059b119 | WT | 101,439 | $710 | dollars as filed | |
| TC BIOPHARM HOLDINGS PLC | 87807D111 | *W EXP 02/10/202 | 18,823 | $376 | dollars as filed | |
| BRUUSH ORAL CARE INC | 11750K120 | *W EXP 08/03/202 | 14,423 | $110 | dollars as filed | |
| Relativity Acquisition Corp | 75944B114 | Warrant | 100,000 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-000943 | this filing | 2024-05-15 | acceptance time not in the bulk data set |